Åsa Johansson

Uppsala University

Scientific Lead for Precision Medicine at SciLifeLab

Key publications

Rask-Andersen M, Ivansson E, Höglund J, Ek WE, Karlsson T, & Johansson Å. Adiposity and sex-specific cancer risk. Cancer Cell 2023 41 . (doi:10.1016/j.ccell.2023.05.010)

Kierczak M, Rafati N, Höglund J, Gourlé H, Faro V Lo, Schmitz D, Ek WE, Gyllensten U, Enroth S, Ekman D, Nystedt B, Karlsson T, & Johansson Å. Contribution of rare whole-genome sequencing variants to plasma protein levels and the missing heritability. Nature Communications 2022 13 1–12. (doi:10.1038/s41467-022-30208-8)

Faro V Lo, Johansson T, & Johansson Å. The risk of venous thromboembolism in oral contraceptive users: the role of genetic factors-a prospective cohort study of 240,000 women in the UK Biobank. American journal of obstetrics and gynecology 2023 . (doi:10.1016/J.AJOG.2023.09.012)

Karlsson T, Rask-Andersen M, Pan G, Höglund J, Wadelius C, Ek WE, & Johansson Å. Contribution of genetics to visceral adiposity and its relation to cardiovascular and metabolic disease. Nature Medicine 2019 25 1390–1395. (doi:10.1038/s41591-019-0563-7)

Rask-Andersen M, Karlsson T, Ek WE, & Johansson Å. Modification of Heritability for Educational Attainment and Fluid Intelligence by Socioeconomic Deprivation in the UK Biobank. The American journal of psychiatry 2021 178 625–634. (doi:10.1176/appi.ajp.2020.20040462)

Ek WE, Karlsson T, Höglund J, Rask-Andersen M, & Johansson Å. Causal effects of inflammatory protein biomarkers on inflammatory diseases. Science Advances 2021 7 eabl4359. (doi:10.1126/sciadv.abl4359)

Research Interests

Every fourth individual in Europe has ever been diagnosed with a common disease, such as cancer, asthma, diabetes, or myocardial infarction. The aim of our research is to determine genetic and lifestyle factors that influence human phenotypes, clinical variables, and risk of disease. We also evaluate how such factors can be used to predict, or even prevent, common diseases. The goal is to broaden our knowledge of disease pathophysiology, which is important for developing drugs to prevent, delay progression, or relieve symptoms of disease.

Group Members

Azimi, Tayebe
Deng, Yaqi
Ek, Weronica
Hadizadeh, Fatemeh
Johansson, Therese
Karlsson, Torgny
Koteci, Ardita
Lo Faro, Valeria
Mutie, Pascal
Rask-Andersen, Mathias
Schmitz, Daniel

Last updated: 2023-12-20

Content Responsible: David Gotthold(david.gotthold@scilifelab.se)